Drug profile · INN
piperacillin sodium
PIPERACILLIN AND TAZOBACTAM
piperacillin sodium (PIPERACILLIN AND TAZOBACTAM) is a bacterial penicillin-binding protein inhibitor. Route of administration: injection. Current US regulatory status: approved.
Drug details — piperacillin sodium
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 10
- Data quality
- 0.84
Quick answer
piperacillin sodium (PIPERACILLIN AND TAZOBACTAM) is a bacterial penicillin-binding protein inhibitor. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Bacterial penicillin-binding protein inhibitor
Primary target: Bacterial penicillin-binding protein
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is piperacillin sodium?
piperacillin sodium (PIPERACILLIN AND TAZOBACTAM) is a bacterial penicillin-binding protein inhibitor. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for piperacillin sodium?
PIPERACILLIN AND TAZOBACTAM is a marketed brand name for piperacillin sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of piperacillin sodium?
piperacillin sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.